Contribution: Industrial Research Assistance Program
Bold Therapeutics Inc.
$75,000.00
Indication expansion and mechanism of action of BOLD-100's neuroprotection
FY 2025-26 · 2026-01-01
Summary
This project will investigate the mode of action of neuroprotective activity of BOLD-100, the Firm's lead metallotherapeutic candidate for cancer therapy.
Department
Program
Industrial Research Assistance Program
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
748003712
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2026-01-01 | 2025-26 | $65,000.00 |
| 1 | 2026-01-01 | 2025-26 | $75,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 10,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 10 000 dollars.
Agreement End Date
2026-07-13
Agreement Number
1038281
Agreement Start Date
2026-01-01
Agreement Title
Indication expansion and mechanism of action of BOLD-100's neuroprotection
Agreement Title (French)
Extension des indications et mécanisme d’action de la neuroprotection du BOLD-100
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2026-06-11
Amendment Number
1
Coverage
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity. | Les projets du Programme d'aide à la recherche industrielle favorisent la création de richesse au Canada grâce à l'innovation technologique et renforcent l'écosystème canadien de l'innovation en créant de nouvelles capacités industrielles.
Description
This project will investigate the mode of action of neuroprotective activity of BOLD-100, the Firm's lead metallotherapeutic candidate for cancer therapy.
Description (French)
Ce projet étudiera le mode d’action de l’activité neuroprotectrice du BOLD-100, le prospect métallothérapeutique de l’entreprise pour le traitement du cancer.
Expected Results
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Expected Results (French)
Les résultats attendus du Programme d’aide à la recherche industrielle du CNRC sont axés sur la croissance des petites et moyennes entreprises (PME) grâce à l’innovation et à la création de richesse pour le Canada.
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program
Program Name (French)
Programme d’aide à la recherche industrielle
Program Purpose
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Program Purpose (French)
Les contributions versées aux entreprises en vertu du Programme d’aide à la recherche industrielle ont pour objectif d’apporter un soutien aux petites et moyennes entreprises (PME) afin qu’elles puissent approfondir leurs connaissances en matière d’innovation et renforcer leur capacité d’innovation, de croissance et de création de richesse pour le Canada.
Recipient Business Number
748003712
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Bold Therapeutics Inc.
Recipient Postal Code
V6B 2Z4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2025-2026-Q4-1038281
